Spring is here—and so is appropriations season in Washington, DC. This month has brought key developments in both the FY26 federal budget process and state-level policy action that could impact gynecologic cancer research, prevention, and patient care. Here’s what advocates need to know: Draft Budget Proposal Would Eliminate Key CDC Cancer Programs A draft of the administration’s … Continued
New administrations inevitably bring changes, both big and small. The top priority of OCRA’s Policy & Advocacy team remains the same—ensuring the voices of the ovarian and gynecologic cancer community are heard and the issues that impact our community are considered. Next month, OCRA’s Advocate Leaders will convene in Washington, DC to once again bring … Continued
In a new article from TheaterMania, ovarian cancer survivor and OCRA Advocate Leader Kristen Jantonio shares how her passion for theater has been a source of strength and inspiration since being diagnosed with ovarian cancer. Through OCRA’s Advocate Leader program, she helps drive policy changes that support the gynecologic cancer community. Learn more in Playhouse Square’s Kristen … Continued
OCRA Joins Forces With Rivkin Center for Ovarian Cancer Research Ovarian Cancer Research Alliance (OCRA) has announced that the Rivkin Center for Ovarian Cancer Research will join with OCRA effective April 1, 2025. This historic collaboration unites two respected organizations committed to advancing research for a cure for ovarian and all gynecologic cancers. “OCRA has always … Continued
Happy New Year from OCRA’s Policy and Advocacy Team! As we step into a new year, we want to take a moment to thank you for your unwavering support and dedication. Each year brings fresh opportunities to drive meaningful change for the ovarian and gynecologic cancer community, and we couldn’t do it without you. Update … Continued
As we close out 2024, we at OCRA are reflecting on a year of powerful advocacy and immense gratitude. Your passion and commitment to raising awareness, driving policy change, and pushing for progress for the ovarian and gynecologic cancer community have left a mark that will be felt for years to come. Here are some … Continued
“To improve patient outcomes – and quality of life – we must minimize roadblocks for access to cancer screenings that could change the course of a diagnosis. The time is now. We are urging Congressional action this week to enact this legislation into law.” The Ovarian Cancer Research Alliance today released the following statement regarding … Continued
OCRA recently joined the Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), which is working to ensure genetic testing access for all who may carry inherited mutations that increase the risk of ovarian and other cancers. The coalition, which includes patient advocacy and industry members, endeavors to drive changes in cancer-related genetic testing policies to expand … Continued
International Forum on Ovarian Cancer Aims to Accelerate Progress Ovarian Cancer Research Alliance (OCRA) President and CEO Audra Moran, along with members of the OCRA team, joined leading scientists and non-profit executives from across the globe this October at the Helene Harris Memorial Trust (HHMT) International Forum on Ovarian Cancer. This prestigious conference, organized by … Continued
Closing out 2024 and Looking Ahead to 2025 As we approach the close of this year’s legislative calendar, the urgency surrounding the federal budget process cannot be overstated. If action is not taken before December 20, the federal government will shut down. At OCRA, we understand that every dollar allocated to cancer research represents hope … Continued
We are weeks away from election day and there is still work to be done! With Congress in recess until after the election, there is a short window of time to make things happen before the end of the year. Right now, the Multi-Cancer Early Detection Act (MCED) and the 2025 appropriations process are among … Continued
The Clearity Foundation Joins The OCRA Family A Special Message from OCRA’s President & CEO Dear OCRA Community, Earlier this week, we shared some exciting news as we close out Ovarian Cancer and Gynecologic Cancer Awareness Month. OCRA is joining forces with The Clearity Foundation, further strengthening our commitment to supporting the ovarian and entire … Continued
Get email updates about research news, action alerts, and ways to join the fight.
